Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jingsheng Hua"'
Autor:
Xiebing Bao, Jingyun Chi, Yiwei Zhu, Minfeng Yang, Jiahui Du, Zaixiang Tang, Xiaogang Xu, Genxiang Mao, Zhibing Wu, Jun Chen, Jingsheng Hua, Ting Xu, Song-Bai Liu
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background As a core member of the FA complex, in the Fanconi anemia pathway, FAAP24 plays an important role in DNA damage repair. However, the association between FAAP24 and patient prognosis in AML and immune infiltration remains unclear.
Externí odkaz:
https://doaj.org/article/5fa7de4e438d43f3b5f18cb2c7e1ea8c
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundAcute myeloid leukemia (AML) is an aggressive hematopoietic malignancy. Transient receptor potential (TRP) channels in AML still need to be further explored. A TRP channel-related model based on machine learning was established in this stud
Externí odkaz:
https://doaj.org/article/a9ed67532b124e8c904c183436638ced
Autor:
Xiebing Bao, Yao Chen, Xiao Lou, Jiahui Du, Huijun Li, Nian Liu, Zaixiang Tang, Jingsheng Hua, Weiqiang Guo, Song-Bai Liu
Publikováno v:
Clinical and Translational Oncology. 25:1053-1066
Acute myeloid leukemia (AML) is a hematological malignancy with high molecular and clinical heterogeneity, and is the most common type of acute leukemia in adults. Due to limited treatment options, AML is prone to relapse and has a poor prognosis. Ex
Autor:
Jingsheng Huang, Weichao Kang, Dandan Yi, Shuxin Zhu, Yifei Xiang, Chengzhi Liu, Han Li, Dejia Dai, Jieyu Su, Jiakang He, Zhengmin Liang
Publikováno v:
Virulence, Vol 15, Iss 1 (2024)
ABSTRACTActinobacillus pleuropneumoniae (APP) is an important pathogen of the porcine respiratory disease complex, which leads to huge economic losses worldwide. We previously demonstrated that Pichia pastoris-producing bovine neutrophil β-defensin-
Externí odkaz:
https://doaj.org/article/c5ff7515a636492da0e97e95eef753c4
Autor:
Xiebing Bao, Lili Zhou, Miao Miao, Yue Han, Weiqing Qian, Huiying Qiu, Jingsheng Hua, Jian Zhang, Caixia Li, Zhengzheng Fu, Depei Wu, Xiaoxia Wu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:610-616
Introduction Currently, effective and safe salvage therapies are limited among patients with relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantation (allo-HSCT). Anti-CD19 chimeric antigen receptor T (CAR T) cel
Autor:
Weiqing Qian, Jian Zhang, Lei Yu, Lili Zhou, Huiying Qiu, Suning Chen, Xiaoxia Wu, Jingsheng Hua
Publikováno v:
OncoTargets and therapy
Pediatric Philadelphia chromosome-like (Ph-like) acute B-lymphoblastic leukemia (B-ALL), a high-risk subset of B-ALL characterized by a gene expression profile similar to that of Ph-positive ALL, has extremely poor outcome after a relapse following
Autor:
Jiexian Ma, Xiaohua Wang, Zhaoling Zou, Mixue Xie, Jingsheng Hua, Youdao Liang, Min Wu, Ruyu Yang, Yingwei Hu, Yu Xu, Yanhui Xie, Xiujin Ye, Xiaoqin Wang
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(10)
Background Decitabine are used in the treatment of myelodysplastic syndrome (MDS), but none trials reported overall survival improvement. Methods High-risk MDS and MDS transformed AML (sAML) patients (IPSS-R > 4.5, age above 60 years) in 6 medical ce
Autor:
Miao Miao, Huiying Qiu, Chengcheng Fu, Xiebing Bao, Depei Wu, Suning Chen, Xiaoxia Wu, Jingsheng Hua, Yue Han, Xinyou Zhang, Jian Zhang, Xiaowen Tang, Lili Zhou, Caixia Li
Publikováno v:
Bone marrow transplantation. 56(5)
The efficacy and safety of donor-derived anti-CD19 CAR T cells vs DLI for the management of relapsed B-cell acute lymphoblastic leukemia (B-ALL) after allo-hematopoietic stem cell transplantation (HSCT) remain unclear. Thirteen B-ALL patients with re
Autor:
Shunrong Sun, Yanhui Xie, Hehe Sheng, Yingwei Hu, Jiexian Ma, Zhaolin Zhou, Min Wu, Mixue Xie, Jingsheng Hua, Ruyu Yang, Xiaohua Wang, Xiaoqin Wang, Xiujin Ye
Publikováno v:
SSRN Electronic Journal.
There is still a lack of effective treatments for elderly AML/MDS patients, especially those with TP53 mutation. We conducted a prospective, multicenter clinical trial to evaluate decitabine and etoposide based regimen in elderly AML/MDS patients and
Publikováno v:
OncoTargets & Therapy. Oct2016, Vol. 9, p6573-6579. 7p.